Multiple steroidogenic enzymes

Multiple steroidogenic enzymes represent a collective group of proteins, primarily cytochrome P450 (CYP) enzymes and hydroxysteroid dehydrogenases (HSDs), responsible for the multi-step conversion of cholesterol into essential steroid hormones (Miller, 2011). Key enzymes in this pathway include CYP11A1 (cholesterol side-chain cleavage), CYP17A1 (17α-hydroxylase/17,20-lyase), 3β-hydroxysteroid dehydrogenase (3β-HSD), and CYP11B1 (11β-hydroxylase) (StatPearls, 2023). These enzymes are predominantly expressed in the adrenal cortex, testes, and ovaries, where they regulate the production of glucocorticoids, mineralocorticoids, and sex steroids (NCBI, 2022). In therapeutic contexts, multiple steroidogenic enzymes are targeted by broad-spectrum inhibitors like ketoconazole and aminoglutethimide to treat conditions characterized by hormone excess, such as Cushing's syndrome or advanced prostate cancer (PubMed, 2020). Because these drugs often lack specificity, they can simultaneously suppress multiple hormonal axes, leading to therapeutic challenges such as primary adrenal insufficiency (StatPearls, 2023). Monitoring biomarkers like serum cortisol and testosterone is essential for managing the efficacy and safety of these multi-target interventions (Mayo Clinic, 2023).

Other names

Steroidogenic pathway enzymesAdrenal steroidogenesis enzymesGonadal steroidogenesis enzymesSteroid biosynthetic enzymes

Inhibition of multiple enzymatic steps in the steroid biosynthetic pathway, typically involving the blockade of cytochrome P450 enzymes (e.g., CYP11A1, CYP17A1, CYP11B1) to reduce the synthesis of cortisol, androgens, and other steroid hormones (Miller, 2011; StatPearls, 2023).